Advertisement
Genotyping may provide some clinical benefit in prescribing antiplatelet therapies for patients undergoing percutaneous coronary intervention

CYP2C19 Genotyping May Aid Antiplatelet Prescribing

0
Benefit only seen for composite outcome, not for major or minor bleeding incidents
Disease-modifying antirheumatic drug therapy for rheumatoid arthritis treatment also cuts cardiovascular disease risk

Early Therapy for Rheumatoid Arthritis May Slow Heart Disease

0
RA treatment response does not appear to impact improvement in vascular stiffness
For patients with diabetes

High Coronary Artery Calcium + Diabetes Even Riskier for Women

0
In adults with diabetes, high CAC score predicts CVD, total mortality more strongly in women than in men
In 2020 European Society of Cardiology guidelines

ESC Updates Guidelines for Adult Congenital Heart Disease

0
Patients with congenital heart disease increasingly present as older adults, including the elderly
Invasive management is beneficial for patients with non-ST elevation myocardial infarction aged 80 years or older

Invasive Treatment Tied to Better Outcomes in Elderly With NSTEMI

0
Mortality, incidence of hospital admission for heart failure lower in ≥80s with invasive management
Ideal cardiovascular health is associated with lower odds for ocular diseases

Cardiovascular Health Tied to Lower Risk for Eye Diseases

0
Findings particularly strong for lowering risk for diabetic retinopathy
Toddlers who are overweight or obese have higher cardiometabolic risk scores at 11 to 12 years of age

Early Body Mass Index Tied to Cardiometabolic Risk at Age 11 to 12

0
Obese children also have higher outcome pulse wave velocity, carotid intima-media thickness
Among patients with heart failure

Empagliflozin Superior to Placebo for Heart Failure

0
Risk for CV death, hospitalization with heart failure reduced, regardless of presence of diabetes
In a synopsis of the 2020 U.S. Department of Veterans Affairs/U.S. Department of Defense clinical practice guideline

VA/DoD Issue Guideline for Diagnosis, Management of HTN

0
Measurement of BP; target treatment goals; nonpharmacologic, pharmacologic therapy discussed
There has been a decline in deaths related to atrial fibrillation over the last 45 years

Deaths From Atrial Fibrillation Declined From 1972 to 2015

0
Two-year gap in life expectancy still exists, compared to individuals without atrial fibrillation